6.
Golbahar J, Altayab D, Carreon E
. Short-term stability of amino acids and acylcarnitines in the dried blood spots used to screen newborns for metabolic disorders. J Med Screen. 2014; 21(1):5-9.
DOI: 10.1177/0969141314525367.
View
7.
Baumgartner C, Baumgartner D
. Biomarker discovery, disease classification, and similarity query processing on high-throughput MS/MS data of inborn errors of metabolism. J Biomol Screen. 2005; 11(1):90-9.
DOI: 10.1177/1087057105280518.
View
8.
Pajares S, Arranz J, Ormazabal A, Del Toro M, Garcia-Cazorla A, Navarro-Sastre A
. Implementation of second-tier tests in newborn screening for the detection of vitamin B related acquired and genetic disorders: results on 258,637 newborns. Orphanet J Rare Dis. 2021; 16(1):195.
PMC: 8086297.
DOI: 10.1186/s13023-021-01784-7.
View
9.
Shen G, Li W, Zhang Y, Chen L
. Next-generation sequencing based newborn screening and comparative analysis with MS/MS. BMC Pediatr. 2024; 24(1):230.
PMC: 10985934.
DOI: 10.1186/s12887-024-04718-x.
View
10.
Chace D, Kalas T, Naylor E
. The application of tandem mass spectrometry to neonatal screening for inherited disorders of intermediary metabolism. Annu Rev Genomics Hum Genet. 2002; 3:17-45.
DOI: 10.1146/annurev.genom.3.022502.103213.
View
11.
Luo X, Wang R, Fan Y, Gu X, Yu Y
. Next-generation sequencing as a second-tier diagnostic test for newborn screening. J Pediatr Endocrinol Metab. 2018; 31(8):927-931.
DOI: 10.1515/jpem-2018-0088.
View
12.
Huang X, Yang L, Tong F, Yang R, Zhao Z
. Screening for inborn errors of metabolism in high-risk children: a 3-year pilot study in Zhejiang Province, China. BMC Pediatr. 2012; 12:18.
PMC: 3306752.
DOI: 10.1186/1471-2431-12-18.
View
13.
Therrell B, Adams J
. Newborn screening in North America. J Inherit Metab Dis. 2007; 30(4):447-65.
DOI: 10.1007/s10545-007-0690-z.
View
14.
Shigematsu Y, Hirano S, Hata I, Tanaka Y, Sudo M, Sakura N
. Newborn mass screening and selective screening using electrospray tandem mass spectrometry in Japan. J Chromatogr B Analyt Technol Biomed Life Sci. 2002; 776(1):39-48.
DOI: 10.1016/s1570-0232(02)00077-6.
View
15.
Padilla C, Therrell B
. Newborn screening in the Asia Pacific region. J Inherit Metab Dis. 2007; 30(4):490-506.
DOI: 10.1007/s10545-007-0687-7.
View
16.
Yang C, Zhou C, Xu P, Jin X, Liu W, Wang W
. Newborn screening and diagnosis of inborn errors of metabolism: A 5-year study in an eastern Chinese population. Clin Chim Acta. 2020; 502:133-138.
DOI: 10.1016/j.cca.2019.12.022.
View
17.
Lin Y, Zheng Q, Zheng T, Zheng Z, Lin W, Fu Q
. Expanded newborn screening for inherited metabolic disorders and genetic characteristics in a southern Chinese population. Clin Chim Acta. 2019; 494:106-111.
DOI: 10.1016/j.cca.2019.03.1622.
View
18.
Wang T, Ma J, Zhang Q, Gao A, Wang Q, Li H
. Expanded Newborn Screening for Inborn Errors of Metabolism by Tandem Mass Spectrometry in Suzhou, China: Disease Spectrum, Prevalence, Genetic Characteristics in a Chinese Population. Front Genet. 2019; 10:1052.
PMC: 6828960.
DOI: 10.3389/fgene.2019.01052.
View
19.
Huang H, Chu K, Chien Y, Wei M, Wu S, Wang S
. Tandem mass neonatal screening in Taiwan--report from one center. J Formos Med Assoc. 2006; 105(11):882-6.
DOI: 10.1016/S0929-6646(09)60173-X.
View
20.
Focardi M, Pinchi V, Defraia B, Gualco B, Varvara G, Norelli G
. Newborn screening of inherited metabolic disorders: the Italian situation. J Biol Regul Homeost Agents. 2016; 30(3):909-914.
View